What's Happening?
ERM and Ayming have established a consortium aimed at reducing the pharmaceutical industry's reliance on petroleum-based solvents, which are significant contributors to greenhouse gas emissions. The consortium, which includes major industry players such
as GSK, Croda, and Cytiva, has received over £7 million in funding from Innovate UK and the Department of Health and Social Care. The initiative focuses on developing bio-based solvents using advanced membrane purification technologies, which promise to be cost-effective and environmentally friendly. The consortium will work over the next 36 months to integrate these alternatives into existing pharmaceutical manufacturing processes without requiring significant infrastructure changes.
Why It's Important?
This initiative is crucial as it addresses the pharmaceutical industry's environmental impact, particularly its contribution to Scope 3 greenhouse gas emissions. By developing and adopting bio-based solvents, the consortium aims to significantly reduce the carbon footprint of pharmaceutical manufacturing. This move aligns with global efforts to combat climate change and supports the UK government's Industrial Strategy for sustainable manufacturing. The success of this project could set a precedent for other industries reliant on petroleum-based products, potentially leading to broader environmental benefits and advancements in sustainable manufacturing practices.
What's Next?
The consortium will focus on the industrialization of bio-based solvents over the next three years, leveraging the expertise of its diverse members. This includes technology providers, solvent manufacturers, and pharmaceutical companies. The project aims to overcome current challenges in achieving the necessary purity and moisture control for pharmaceutical applications. If successful, the initiative could lead to widespread adoption of bio-based solvents in the pharmaceutical industry, potentially influencing regulatory standards and encouraging further investment in sustainable technologies.
